192 related articles for article (PubMed ID: 32552842)
41. Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake.
Jeong YH; Kim D; Lee JW; Rhee Y; Nam KH; Yun M; Kim CK
Clin Nucl Med; 2015 Aug; 40(8):632-6. PubMed ID: 26018720
[TBL] [Abstract][Full Text] [Related]
42. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
[TBL] [Abstract][Full Text] [Related]
43. The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
Shi X; Liu Y; Zhang X; Yi C; Wang X; Chen Z; Zhang B
Clin Nucl Med; 2013 Jul; 38(7):522-6. PubMed ID: 23698463
[TBL] [Abstract][Full Text] [Related]
44. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH
J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430
[TBL] [Abstract][Full Text] [Related]
45. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
Castilla-Lièvre MA; Franco D; Gervais P; Kuhnast B; Agostini H; Marthey L; Désarnaud S; Helal BO
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):852-859. PubMed ID: 26577938
[TBL] [Abstract][Full Text] [Related]
47. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
[TBL] [Abstract][Full Text] [Related]
48. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
49. Improving the Diagnostic Performance of
Swart LE; Gomes A; Scholtens AM; Sinha B; Tanis W; Lam MGEH; van der Vlugt MJ; Streukens SAF; Aarntzen EHJG; Bucerius J; van Assen S; Bleeker-Rovers CP; van Geel PP; Krestin GP; van Melle JP; Roos-Hesselink JW; Slart RHJA; Glaudemans AWJM; Budde RPJ
Circulation; 2018 Oct; 138(14):1412-1427. PubMed ID: 30018167
[TBL] [Abstract][Full Text] [Related]
50. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
51. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
52. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
53.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
Son GM; Kim SJ
Abdom Radiol (NY); 2019 Feb; 44(2):456-463. PubMed ID: 30132094
[TBL] [Abstract][Full Text] [Related]
55. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
56. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
57. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
Mitra A; Pencharz D; Davis M; Wagner T
Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
[TBL] [Abstract][Full Text] [Related]
58. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
59. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
60. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
Frille A; Steinhoff KG; Hesse S; Grachtrup S; Wald A; Wirtz H; Sabri O; Seyfarth HJ
Medicine (Baltimore); 2016 Jun; 95(25):e3976. PubMed ID: 27336898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]